#Gene Expression Analysis Market Share

[trendingreportz]

Genomics Market - Forecast(2024 - 2030)

Global Genomic Market Overview:

A genome is the genetic material of an organism. It includes both the genes and the noncoding DNA, as well as mitochondrial DNA and chloroplast DNA. The study of genomes is called genomics. The genomics market is gaining traction owing to its applications in various fields of study such as intragenomic phenomenon including epistasis, pleiotropy, heterosis, and other interactions between loci and alleles within the genome. In this era of medical and life science innovations shaping itself as an inevitable uptake for sustainability of mankind, the genomic research is poised for exponential growth owing to imperative genetic innovations feeding off it. Abundant potential has driven this arcade to reach a staggering market size of $16 billion - $16.5 billion as of 2018, and the demand is estimated to increment at formidable CAGR of 9.2% to 10.2% during the forecast period of 2019 to 2025.

Request Sample

Global Genomic Market Outlook:

Genomics is extensively employed in healthcare, agriculture, biotechnology, DNA sequencing, and diagnostics. In the healthcare segment, genomics is used for the development of vaccines and drugs. This segment leads the application vertical and is growing with a CAGR of 10.1%-10.7 % through to 2025. Genomics plays a significant part in diagnosis of several genetic disorders. It has an ample scope in personalized medication as it can advocate a medical management constructed on the genetic face of a person with the help of clinical data and AI.  It is also applied in synthetic biology and bioengineering. Genomics research in agriculture is hired for plant breeding and genetics to cultivate crop production. The understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant will aid the plant breeders to identify the traits and then manipulate those traits to obtain a high yield. All these factors affecting the enormous medical and agricultural sector are all set to stroke the genomics market with abundant demand.

Inquiry Before Buying

Global Genomic Market Growth Drivers:

As per the National Center for Biotechnology Information, U.S, the progression in oncology (study and treatment of tumor) expenses is forecast to rise 7%–10% annually throughout 2020, with universal oncology cost exceeding $150 billion[1]. As per the WHO, cancer is a leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018[2]. And the total annual economic cost of cancer at the initial period of this decade was estimated at approximately $1.16 trillion. Thus the application of genomics in exploring cell-free circulating DNA by several R&D sectors as a potential biomarker for cancers is driving the market towards exponential growth. The genomics market with its current potential displays all the necessary traits it can adapt in the coming years to divert a huge chunk of traffic and revenue from the omnipresent cancer diagnostics.

As per the Food and Agriculture Organization of United Nations, between 1960 and 1990 the arable land increased by 1.5 billion ha, and in the recent past decades the elevation recorded is just 155 million ha[3]. With decreasing arable floor and the increasing global population augmenting the demand for food by 70% (by 2050), obtaining a high yield is a major trend in the agricultural sector. Genomics market is all set to capitalize on this unprecedented demand scenario. Genomics supplements the understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant, thus aiding the plant breeders to identify the traits and then manipulate those traits to obtain a high yield.

After an acute analysis of the regional insights of the global genomics market, North America is revealed to hold 39% to 40% of the entire global market size as of 2018. Such dominance can be attributed to several aspects such as cumulative investment on research by federal administrations, growing patient awareness, and accessibility of urbane healthcare facilities.

Schedule a Call

Global Genomics Market Players Perspective:

Some of other key players profiled in this IndustryARC business intelligence report are Beckton Dickson, Synthetic Genomics Inc. (SGI) ,Cepheid, Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, GE Healthcare, Illumina, Inc., Danaher Corporation,F. Hoffmann-La Roche, QIAGEN, Thermo Fisher Scientific and PacBio (Pacific Biosciences of California). Majority of the companies mentioned are situated in North America augmenting the regional affluence in the global market.

Global Genomics Market Trends:

High overload owing to a wide range of reagents and consumables has propelled companies into approving different policies to endure in the market and stay ahead of the curve.

For instance, in January 2017, BD launched Precise WTA Reagents for precise and guileless quantification of hereditary data form single cell analysis. Moreover, in July 2016, SGI-DNA entered into a distribution agreement with VWR International, an American company involved in the distribution of research laboratory products, with over 1,200,000 items to more than 250,000 customers in North America and Europe.

Genomics Market Research Scope

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Genomics Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of equipment in the Genomics Market, and their specific applications in different phases of industrial operations.

Buy Now

Genomics Market Report: Industry Coverage

Types of Solutions Genomics Market:

By Product Types- Microarray chip, Sequencers.

By Application- Genotyping, SNP analysis.

By End-User- Anthropology, Diagnostics.

The Genomics Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

[mmarketdbmr]

Companion Diagnostics Market – Industry Trends and Forecast to 2028 Companies: Growth, Share, Value, Analysis, and Trends

Companion Diagnostics Market Size And Forecast by 2028

According to Data Bridge Market Research The companion diagnostics market is expected to witness market growth at a rate of 13.85% in the forecast period of 2021 to 2028

Our comprehensive Companion Diagnostics Market report is ready with the latest trends, growth opportunities, and strategic analysis. https://www.databridgemarketresearch.com/reports/global-companion-diagnostics-market

**Segments**

- **Technology**: The companion diagnostics market can be segmented based on technology into polymerase chain reaction (PCR), in-situ hybridization, immunohistochemistry (IHC), next-generation sequencing (NGS), and others. PCR is widely used due to its high specificity and sensitivity in detecting genetic mutations. In-situ hybridization is preferred for analyzing gene amplifications or translocations. IHC is commonly used to analyze protein expression levels. NGS allows for the analysis of multiple genetic alterations simultaneously, making it a powerful tool in precision medicine.

- **Indication**: Segmentation based on indication includes oncology, cardiovascular diseases, infectious diseases, neurology, and others. Oncology holds a significant share in the market as companion diagnostics play a crucial role in personalized cancer therapy. Cardiovascular diseases are also driving market growth, with the need for targeted therapies. Infectious diseases segment is witnessing growth due to the demand for rapid and accurate diagnostic solutions.

- **End User**: The companion diagnostics market can be segmented by end user into pharmaceutical companies, diagnostic companies, research institutes, and others. Pharmaceutical companies are the major users of companion diagnostics as they incorporate these tests in clinical trials to select appropriate patient populations for targeted therapies. Diagnostic companies play a vital role in developing and commercializing companion diagnostic tests. Research institutes contribute to the advancement of companion diagnostics through collaborative studies and technological innovations.

**Market Players**

- **Roche Diagnostics**: A leading player in the companion diagnostics market, Roche offers a wide range of companion diagnostic tests across multiple disease areas. The company's expertise in personalized healthcare has positioned it as a key player in the market.

- **Qiagen N.V.**: Qiagen is known for its molecular diagnostics solutions, including companion diagnostic tests for oncology. The company's innovative technologies and strong market presence contribute to its significant market share.

- **Abbott Laboratories**: Abbott offers companion diagnostics for various therapies, enhancing treatment outcomes for patients. The company's commitment to precision medicine drives its success in the companion diagnostics market.

- **Thermo Fisher Scientific**: Thermo Fisher Scientific provides a comprehensive portfolio of companion diagnostic solutions, catering to the diverse needs of healthcare professionals. The company's focus on research and development ensures the continuous advancement of companion diagnostics.

- **Agilent Technologies**: Agilent Technologies specializes in molecular and clinical diagnostics, offering cutting-edge companion diagnostic tools for precision medicine applications. The company's dedication to quality and innovation makes it a key player in the market.

The companion diagnostics market is poised for significant growth, driven by advancements in personalized medicine and the rising prevalence of chronic diseases. With key players investing in research and development to expand their product portfolios, the market is expected to witness continued expansion in the coming years.

https://www.databridgemarketresearch.com/reports/global-companion-diagnostics-market Companion diagnostics have emerged as a crucial component of personalized medicine, offering tailored treatment options based on individual patient characteristics. The market is witnessing significant growth due to the increasing focus on precision medicine and the demand for targeted therapies for various diseases. As technology continues to advance, the companion diagnostics market is expected to evolve with innovative solutions that enhance diagnostic accuracy and patient outcomes.

One noteworthy trend in the companion diagnostics market is the growing adoption of next-generation sequencing (NGS) technology. NGS allows for the analysis of multiple genetic alterations simultaneously, providing healthcare professionals with a comprehensive view of a patient's molecular profile. This technology plays a vital role in guiding treatment decisions, particularly in oncology, where targeted therapies based on specific genetic mutations have shown promising results. The use of NGS in companion diagnostics is expected to expand across other disease areas, driving market growth further.

In addition to technological advancements, the segmentation based on indications is also shaping the companion diagnostics market landscape. Oncology remains a key segment due to the critical role companion diagnostics play in personalized cancer therapy. With the increasing prevalence of cancer worldwide, the demand for companion diagnostics in oncology is expected to rise significantly. Cardiovascular diseases and infectious diseases segments are also witnessing growth, with a focus on targeted therapies and rapid diagnostic solutions, respectively. Neurology is another emerging segment where companion diagnostics are playing an important role in advancing personalized treatment approaches.

The end-user segmentation in the companion diagnostics market highlights the diverse stakeholders driving market growth. Pharmaceutical companies are leveraging companion diagnostics in clinical trials to identify suitable patient populations for targeted therapies, thereby enhancing drug development processes. Diagnostic companies are instrumental in developing and commercializing companion diagnostic tests, ensuring their availability to healthcare providers. Research institutes play a critical role in advancing companion diagnostics through collaborative studies and technological innovations, contributing to the expansion of the market.

Market players such as Roche Diagnostics, Qiagen N.V., Abbott Laboratories, Thermo Fisher Scientific, and Agilent Technologies are at the forefront of the companion diagnostics market, offering a wide range of innovative solutions across different disease areas. These key players' investments in research and development have been instrumental in expanding the product portfolios and driving market growth. As the demand for personalized medicine continues to grow, the companion diagnostics market is poised for further expansion, with a focus on improving diagnostic accuracy, treatment outcomes, and patient care overall.**Segments**

- **Global Companion Diagnostics Market, By Product and Services** - Assay Kits and Reagents - Software & Services

- **Technology** - Polymerase Chain Reaction - Molecular Diagnostics - FISH - CISH - Immunohistochemistry - Real-time PCR - Next-Generation Sequencing - Gene Sequencing - In Situ Hybridization

- **Indication** - Oncology - Neurology - Infectious Diseases

- **Application** - Colorectal Cancer - Breast Cancer - Lung Cancer - Melanoma - Urology - Gastric Cancer

- **End Users** - Pharmaceutical and Biopharmaceutical Companies - Reference Laboratories

- **Country** - U.S. - Canada - Mexico - Germany - Italy - U.K. - France - Spain - Netherlands - Belgium - Switzerland - Turkey - Russia - Rest of Europe - Japan - China - India - South Korea - Australia - Singapore - Malaysia - Thailand - Indonesia - Philippines - Rest of Asia-Pacific - Brazil - Argentina - Rest of South America - South Africa - Saudi Arabia - UAE - Egypt - Israel - Rest of Middle East & Africa

**Market Players**

- F. Hoffmann-La Roche Ltd. - Qiagen - Abbott - Almac Group - Agilent Technologies, Inc. - Clinical Lab Products - Myriad Genetics, Inc. - Leica Biosystems Nussloch GmbH - Resonance Health - ARUP Laboratories - Life Technologies Tm - Sysmex Corporation - Thermo Fisher Scientific Inc. - Illumina, Inc. - Hologic, Inc. - Abnova Corporation - bioMérieux SA - Siemens Healthcare Private Limited

The global companion diagnostics market is witnessing a robust growth trajectory, fueled by the increasing focus on personalized medicine and the demand for targeted therapies across various disease indications. The market segmentation based on product and services, technology, indication, application, end users, and country provides a comprehensive understanding of the dynamic landscape of companion diagnostics. The utilization of advanced technologies such as NGS and IHC, coupled with the pivotal role of companion diagnostics in oncology, infectious diseases, and neurology, underlines the significant growth potential of the market.

Key market players such as Roche Diagnostics, Qiagen, Abbott Laboratories, Thermo Fisher Scientific, and Agilent Technologies are driving the market forward with their innovative solutions and strategic investments in research and development. These players are instrumental in shaping the market landscape and meeting the evolving needs of healthcare professionals and patients. The competitive analysis conducted by industry experts offers insights into the market share and competitive strengths of each major player, both on a global scale and regionally. As the companion diagnostics market continues to expand, fueled by industry trends and technological advancements, it is poised for further growth and innovation in the coming years.

The market is highly fragmented, with a mix of global and regional players competing for market share. To Learn More About the Global Trends Impacting the Future of Top 10 Companies in Companion Diagnostics Market :   https://www.databridgemarketresearch.com/reports/global-companion-diagnostics-market/companies

Key Questions Answered by the Global Companion Diagnostics Market Report:

What is the current state of the Companion Diagnostics Market, and how has it evolved?

What are the key drivers behind the growth of the Companion Diagnostics Market?

What challenges and barriers do businesses in the Companion Diagnostics Market face?

How are technological innovations impacting the Companion Diagnostics Market?

What emerging trends and opportunities should businesses be aware of in the Companion Diagnostics Market?

Browse More Reports:

https://www.databridgemarketresearch.com/reports/global-point-of-care-poc-clinical-chemistry-and-immunodiagnostic-markethttps://www.databridgemarketresearch.com/reports/global-anion-sanitary-pads-markethttps://www.databridgemarketresearch.com/reports/global-overall-equipment-effectiveness-software-markethttps://www.databridgemarketresearch.com/reports/global-medical-device-tray-markethttps://www.databridgemarketresearch.com/reports/global-bookbinding-materials-market

Data Bridge Market Research:

☎ Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 982

✉ Email: corporatesales@databridgemarketresearch.com

[mpkpr]

miRNA Sequencing and Assay Market: Insights, Key Players, and Growth Analysis 2031

"The miRNA Sequencing and Assay Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2031. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Brief Overview of the miRNA Sequencing and Assay Market:

The global miRNA Sequencing and Assay Market is expected to experience substantial growth between 2024 and 2031. Starting from a steady growth rate in 2023, the market is anticipated to accelerate due to increasing strategic initiatives by key market players throughout the forecast period.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-mirna-sequencing-and-assay-market

Which are the top companies operating in the miRNA Sequencing and Assay Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global miRNA Sequencing and Assay Market report provides the information of the Top Companies in miRNA Sequencing and Assay Market in the market their business strategy, financial situation etc.

Thermo Fisher Scientific, Inc., (U.S.), Illumina, Inc., (U.S.), QIAGEN, (Netherlands), PerkinElmer, Inc., (U.S.), Abcam plc, (U.K.), New England Biolabs, (U.S.), Takara Bio Inc., (Japan), Lexogen GmbH, (Austria), Norgen Biotek Corp., (Canada), Maravai LifeSciences, (U.S.), HTG Molecular Diagnostics, Inc., (U.S.), Meridian Bioscience, Inc., (U.S.), System Biosciences, LLC., (U.S.)

Report Scope and Market Segmentation

Which are the driving factors of the miRNA Sequencing and Assay Market?

The driving factors of the miRNA Sequencing and Assay Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

miRNA Sequencing and Assay Market - Competitive and Segmentation Analysis:

**Segments**

- miRNA Sequencing - miRNA Assay

The global miRNA sequencing and assay market is expected to witness significant growth from 2021 to 2031. The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders is driving the demand for miRNA sequencing and assays. miRNAs are small non-coding RNA molecules that play a crucial role in gene expression regulation and have been linked to various diseases, making them a key focus of research in the field of molecular biology. The miRNA sequencing segment is projected to dominate the market due to its ability to provide valuable insights into the expression patterns of miRNAs, aiding in the development of novel diagnostic and therapeutic options. On the other hand, the miRNA assay segment is also expected to witness substantial growth, driven by the increasing adoption of miRNA-based diagnostic tests in personalized medicine and drug development.

**Market Players**

- Thermo Fisher Scientific Inc. - QIAGEN - Illumina, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Merck KGaA - PerkinElmer Inc. - GenScript - New England Biolabs - Lexogen

Key market players in the global miRNA sequencing and assay market are continuously focusing on research and development activities to introduce innovative products and strengthen their market presence. Companies are also engaging in strategic collaborations, mergers, and acquisitions to expand their product offerings and enhance their technological capabilities in miRNA research. The intense competition in the market is leading to the introduction of advanced sequencing and assay technologies, catering to the evolving needs of researchers and clinicians in understanding the role of miRNAs in disease pathogenesis and progression.

The global miRNA sequencing and assay market is experiencing steady growth, driven by the increasing research activities in the field of genomics and personalized medicine. The market is witnessing a surge in demand for high-throughput sequencing and sensitive assay technologies that can accurately detect and quantify miRNAsThe global miRNA sequencing and assay market is poised for significant growth during the forecast period, primarily fueled by the escalating incidence of chronic diseases and the expanding applications of miRNA research in disease diagnosis and therapy. The miRNA sequencing segment is anticipated to maintain its dominance in the market as it offers a comprehensive understanding of miRNA expression patterns, facilitating the identification of potential biomarkers and therapeutic targets. The capability of miRNA sequencing to provide deep insights into the regulatory role of miRNAs in gene expression makes it a valuable tool in molecular biology research and clinical diagnostics.

Moreover, the miRNA assay segment is expected to witness notable growth due to the increasing adoption of miRNA-based diagnostic tests for personalized medicine and drug development. The advancements in assay technologies have enabled the detection and quantification of miRNAs with high sensitivity and specificity, paving the way for the development of precise diagnostic tools for various diseases. The integration of miRNA assays in clinical practice is revolutionizing the field of precision medicine by offering tailored treatment options based on individual miRNA profiles.

Key market players such as Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., and others are actively involved in developing novel sequencing and assay platforms to cater to the evolving needs of researchers and clinicians. These companies are heavily investing in research and development to launch innovative products with enhanced performance and user-friendly features. Additionally, strategic collaborations and partnerships with academic institutions, research organizations, and pharmaceutical companies are further propelling the market growth by fostering knowledge exchange and technological advancements in miRNA research.

The market competition is intensifying as companies strive to differentiate their products through technological advancements and product innovations. The focus is on enhancing the throughput, accuracy, and scalability of sequencing and assay platforms to meet the growing demand for high-quality miRNA analysis tools. Market players are also emphasizing on expanding their global presence through geographical expansions and distribution agreements to tap into new market opportunities and strengthen their market position.

Overall, the global miRNA sequencing and assay market presents lucrative opportunities for**Market Players** Thermo Fisher Scientific, Inc. Illumina, Inc. QIAGEN PerkinElmer, Inc. Abcam plc New England Biolabs Takara Bio Inc. Lexogen GmbH Norgen Biotek Corp. Maravai LifeSciences HTG Molecular Diagnostics, Inc. Meridian Bioscience, Inc. System Biosciences, LLC.

The global miRNA sequencing and assay market is witnessing significant growth propelled by the escalating incidence of chronic diseases and the expanding applications of miRNA research in disease diagnosis and therapy. Key market players such as Thermo Fisher Scientific Inc., Illumina, Inc., QIAGEN, and others are actively engaged in developing innovative sequencing and assay platforms to meet the evolving needs of researchers and clinicians. These companies are heavily investing in research and development to introduce cutting-edge products with enhanced performance and user-friendly features.

Strategic collaborations and partnerships with academic institutions, research organizations, and pharmaceutical companies are driving market growth by fostering knowledge exchange and technological advancements in miRNA research. The market competition is intensifying as companies focus on differentiating their products through technological advancements and product innovations. Emphasis is placed on enhancing the throughput, accuracy, and scalability of sequencing and assay platforms to meet the increasing demand for high-quality miRNA analysis tools.

The global miRNA sequencing and assay market presents lucrative opportunities for market players to expand their global presence through geographical expansions and distribution

North America, particularly the United States, will continue to exert significant influence that cannot be overlooked. Any shifts in the United States could impact the development trajectory of the miRNA Sequencing and Assay Market. The North American market is poised for substantial growth over the forecast period. The region benefits from widespread adoption of advanced technologies and the presence of major industry players, creating abundant growth opportunities.

Similarly, Europe plays a crucial role in the global miRNA Sequencing and Assay Market, expected to exhibit impressive growth in CAGR from 2024 to 2031.

Explore Further Details about This Research miRNA Sequencing and Assay Market Report https://www.databridgemarketresearch.com/reports/global-mirna-sequencing-and-assay-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.

Neutral perspective on the miRNA Sequencing and Assay Market scenario

Recent industry growth and new developments

Competitive landscape and strategies of key companies

The Historical, current, and estimated miRNA Sequencing and Assay Market size in terms of value and size

In-depth, comprehensive analysis and forecasting of the miRNA Sequencing and Assay Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters

The countries covered in the miRNA Sequencing and Assay Market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of the Middle East and Africa

Detailed TOC of miRNA Sequencing and Assay Market Insights and Forecast to 2031

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: miRNA Sequencing and Assay Market Landscape

Part 05: Pipeline Analysis

Part 06: miRNA Sequencing and Assay Market Sizing

Part 07: Five Forces Analysis

Part 08: miRNA Sequencing and Assay Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: miRNA Sequencing and Assay Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

Waterproof Speaker Market – Industry Trends and Forecast Camel Milk Cheese Market – Industry Trends and Forecast Asia-Pacific Cargo Inspection Market – Industry Trends and Forecast Molecular Blood Typing, Grouping and Infectious Disease NAT Market – Industry Trends and Forecast Service Lifecycle Management Market – Industry Trends and Forecast 3D Printing High Performance Plastic Market – Industry Trends and Forecast Benzaldehyde Market – Industry Trends and Forecast Geomarketing Market – Industry Trends and Forecast Neurovascular Embolization Devices Market – Industry Trends and Forecast Owren's Disorder Market – Industry Trends and Forecast Anomaly Detection Market – Industry Trends and Forecast Electrocardiography (ECG) Telemetry Devices Market – Industry Trends and Forecast Leadless Cardiac Pacemaker Market – Industry Trends and Forecast Point of Purchase Packaging Market – Industry Trends and Forecast Automotive Trims Tab Market – Industry Trends and Forecast

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 978

Email:- corporatesales@databridgemarketresearch.com "

[anujmrfr]

Reporter Gene Assay Market Size, Growth Outlook 2035

Reporter Gene Assay Market Size was valued at USD 2.35 billion in 2023. The industry is projected to grow from USD 2.55 billion in 2024 to USD 5.11 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.07% during the forecast period (2024 - 2032).

Market Overview

The Reporter Gene Assay Market is growing significantly due to its crucial role in gene expression analysis, drug discovery, and biotechnology research. Reporter gene assays are widely used to monitor cellular events such as transcriptional activity, protein interactions, and signal transduction. These assays are integral in biopharmaceutical development and screening of potential drug candidates.

Market Size and Share

Reporter Gene Assay Market Size was valued at USD 2.35 billion in 2023. The industry is projected to grow from USD 2.55 billion in 2024 to USD 5.11 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.07% during the forecast period (2024 - 2032). The global market for reporter gene assays is expanding rapidly, with pharmaceutical and biotechnology companies being the primary end-users. The increasing demand for high-throughput screening (HTS) technologies and the adoption of bioluminescence-based assays are fueling market growth. North America holds the largest market share due to advanced research infrastructure, while Asia-Pacific is witnessing rapid growth due to increasing investments in genetic research.

Growth Drivers

Rising Demand for Drug Discovery: Reporter gene assays are extensively used in preclinical and clinical research for drug efficacy evaluation.

Advancements in Cell-Based Assays: The integration of fluorescence and luminescence-based detection methods is improving assay sensitivity.

Growing Focus on Personalized Medicine: The adoption of reporter gene technology in gene therapy and biomarker research is expanding applications.

Expanding Biopharmaceutical Industry: The growing number of biologic drugs and cell-based therapies is increasing the demand for reporter gene assays.

Challenges and Restraints

High Costs of Advanced Assay Kits: The pricing of cell-based assays can be a barrier for smaller research labs.

Stringent Regulatory Approvals: Compliance requirements for gene expression assays can slow market expansion.

Technical Limitations: Variability in gene expression results and interference in signal detection pose challenges.

Regional Analysis

North America: Leading the market due to strong R&D funding, presence of biotech firms, and extensive use of gene expression assays in drug research.

Europe: Growing adoption of cell-based assays in biopharmaceutical production and clinical research.

Asia-Pacific: Emerging as a key market due to increased investment in biotech research, expansion of contract research organizations (CROs), and government funding in genomics projects.

Segmental Analysis

The market is segmented based on:

Product Type:

Luciferase Assays

Fluorescent Protein Assays

β-Galactosidase Assays

Secreted Alkaline Phosphatase (SEAP) Assays

Application:

Drug Discovery

Gene Expression Analysis

Signal Transduction Studies

Cancer Research

End-User:

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Contract Research Organizations (CROs)

Key Market Players

Takara Bio

Sartorius AG

BioRad Laboratories

QIAGEN

Roche

Enzo Life Sciences

Recent Developments

Advancements in CRISPR-based reporter assays for precise gene function analysis.

Growing use of luminescent assays for real-time monitoring of gene expression.

Partnerships between biotech firms and pharmaceutical companies for high-throughput screening solutions.

For more information, please visit us at @marketresearchfuture.

[kristinahertzz]

Epigenetics Market

Epigenetics Market Size, Share, Trends: Illumina, Inc. Leads

Growing Demand for Personalized Medicine Drives Market Forward

Market Overview: 

The global Epigenetics Market is projected to grow significantly from 2024 to 2031. North America currently dominates the market, followed by Europe and Asia-Pacific. Key metrics include increasing research activities, rising prevalence of cancer and other chronic diseases, and growing investments in epigenetics research. The market is expanding rapidly, owing to advances in epigenetic technologies, increased applications in drug discovery and development, and growing awareness of personalised medicine. The incorporation of epigenetics into precision medicine, as well as the creation of epigenetic biomarkers for various diseases, are also helping to drive market growth.

DOWNLOAD FREE SAMPLE

Market Trends: 

The field of epigenetics has made significant advances in recent years, particularly in cancer treatment. Epigenetic changes play an essential role in cancer formation and progression, making them prime candidates for therapeutic approaches. Researchers and pharmaceutical companies are increasingly focusing on creating epigenetic treatments to address various types of cancer. These treatments aim to repair abnormal epigenetic alterations and restore normal gene expression patterns in cancer cells. The expanding amount of evidence supporting the efficacy of epigenetic therapies in clinical trials has sparked interest from both healthcare providers and patients. This trend is projected to fuel market expansion as more epigenetic treatments undergo clinical trials and gain regulatory approval.

Market Segmentation: 

Reagents are the largest sector in the epigenetics market by product type, accounting for more than 40% of the market share. This dominance can be ascribed to the extensive use of reagents in epigenetic research and diagnostic applications. Reagents are required for several epigenetic procedures, including DNA methylation analysis, chromatin immunoprecipitation (ChIP), and histone modification research. The segment's expansion is driven by the ongoing requirement for these reagents in academic research and pharmaceutical drug discovery initiatives. Recent advances in the reagent industry include the advent of more sensitive and selective antibodies for detecting epigenetic changes, increasing the accuracy of epigenetic profiling.

Market Key Players: 

Prominent players in the Epigenetics market include Illumina, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Qiagen N.V., Abcam plc, Active Motif, Inc., Diagenode S.A., F. Hoffmann-La Roche Ltd., Zymo Research Corporation, and New England Biolabs. These companies are at the forefront of the industry, continuously innovating and expanding their product portfolios to meet the evolving market demands. Their strategic initiatives and robust distribution networks have enabled them to maintain a strong market presence and drive growth.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[global-research-report]

Exploring the Latin America Gene Expression Market

The Latin America gene expression market size is expected to reach USD 578.3 million by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.6% from 2020 to 2027. High investment in alternative approaches for drug discovery and an increased number of projects involving genetic studies are expected to drive demand.

The region is characterized by fragmented healthcare and a high rate of poverty as well as disparities to access to standard care for cancer and other complex disorders. In this region, consumers from public settings are unable to afford targeted therapies. The number of facilities providing genomic platforms is limited in the region. These factors have resulted in the low revenue share of the Latin America market in the global market for gene expression.

However, researchers and healthcare providers are pursuing training for the use of genomic platforms and constantly participating in genomic projects. Currently, a medical practice based on precision medicine is still a challenge and limited to private settings in Latin America. A rise in the number of research studies pertaining to gene expression, genomic medicine, and personalized medicine in the LATAM region is expected to drive the market.

The Brazilian Initiative on Precision Medicine (BIPMed) is the first Latin American and Brazilian beacon, which is a genetic mutation sharing platform established by the Global Alliance for Genomics and Health (GA4GH). BIPMed encourages propagation and guidance in areas of computational ecology, personalized medicine, molecular hereditary, and others. This initiative plays an important role in the development of precision medicine in Latin America, thereby enabling significant advancements in healthcare and research in this region.

Latin America Gene Expression Market Report Highlights

cDNA synthesis and conversion accounted for the largest revenue share in 2019. The introduction of systems that provide direct library synthesis eliminating the need for prior steps is expected to increase the revenue share of the segment

Kits and reagents generated the largest product revenue in 2019 owing to the commercial availability of a broad range of kits and reagents to support biological discoveries and advancements

Moreover, the introduction of enhanced kits and reagents that support better workflow, also contributes to segment growth

Availability of products with higher efficiency, better adoption to specific research need, and decline in prices of associated techniques is projected to drive growth in the coming years

High-Plex capacity is expected to witness the fastest CAGR from 2020 to 2027. The segment also accounted for the largest revenue share owing to high adoption in clinical and drug discovery uses

Increased demand for advanced diagnostic solutions is expected to fuel the growth of the clinical diagnostics segment

RNA expression dominated the technique segment. Technological advances in RNA expression tools and techniques coupled with the availability of a range of products to meet different research needs are anticipated to increase the adoption of these techniques for gene expression analysis

Brazil accounted for the largest revenue generation in 2019 owing to continuous developments in genomicand healthcare-related research in the country

Competition in the market is high due to the presence of a substantial number of well-established companies and small- to mid-sized entities

Key players are manufacturing and commercializing products to cater to various requirements in gene expression. To maintain a significant share in the market, players have implemented several business strategies including the expansion of distribution network, product portfolio, and increase in manufacturing capacity through mergers and collaborations

Latin America Gene Expression Market Segmentation

Grand View Research has segmented the Latin America gene expression market on the basis of process, product, capacity, application, technique, and region:

Latin America Gene Expression Process Outlook (Revenue, USD Million, 2016 - 2027)

Sample Collection

Purification

cDNA Synthesis & Conversion

PCR Analysis

Data Analysis & Interpretation

Latin America Gene Expression Product Outlook (Revenue, USD Million, 2016 - 2027)

Kits & Reagents

DNA Chips

Others

Latin America Gene Expression Capacity Outlook (Revenue, USD Million, 2016 - 2027)

Lolex 

Latin America Gene Expression Application Outlook (Revenue, USD Million, 2016 - 2027)

Drug Discovery & Development

Clinical Diagnostics

Biotech & Microbiology

Others 

Latin America Gene Expression Technique Outlook (Revenue, USD Million, 2016 - 2027)

RNA Expression

Northern Blotting

DNA Microarrays

PCR Techniques

RNA-Sequencing

Promoter Analysis

In vitro Transcription/Nuclear Run-On Assays

Gel Shift Assays

Chromatin Immunoprecipitation (ChIP)

Protein Expression & Posttranslational Modification Analysis

Western Blotting

2-D Gel Electrophoresis

Immunoassays

Mass Spectrometry

Latin America Gene Expression Regional Outlook (Revenue, USD Million, 2016 - 2027)

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Peru

Ecuador

Dominican Republic (República Dominicana)

Venezuela

Guatemala

Panama

Costa Rica

Uruguay

Cuba

Order a free sample PDF of the Latin America Gene Expression Market Intelligence Study, published by Grand View Research.

[jameswilliam4u]

Global DNA Microarray Market Outlook, Growth, Share, Trends, Size & Forecast | 2024 - 2032

The DNA microarray market has emerged as a vital component of genomics research and clinical diagnostics, providing robust solutions for gene expression analysis, mutation detection, and disease profiling. Valued at USD 5.14 billion in 2023, the market is poised for substantial growth with a forecasted CAGR of 10.6% from 2024 to 2032, potentially reaching USD 12.69 billion by 2032. This blog delves into the critical aspects shaping the DNA microarray market, including key players, trends, segments, and the impact of COVID-19.

[farmacuticals]

Exploring Growth Opportunities in the Reporter Gene Assay Market: Trends and Future Outlook

A Reporter Gene Assay is a powerful tool used in molecular biology to study gene expression, regulation, and cellular signaling. This technique involves inserting a reporter gene, such as luciferase, GFP (green fluorescent protein), or β-galactosidase, into the genome of a cell or organism. The expression of this reporter gene is then measured to indicate the activity of the gene or pathway under study. This assay is widely used in both basic and applied research, as it provides quantifiable data on the effects of various treatments, environmental conditions, or genetic modifications on gene expression.

The Reporter Gene Assay Market Size was projected as 16.19 (USD Billion) in 2022 based on MRFR analysis. It is anticipated that the market for reporter gene assays would increase from 17.46 billion USD in 2023 to 34.5 billion USD in 2032. Throughout the forecast period (2024–2032), the Reporter Gene Assay Market is anticipated to develop at a CAGR of approximately 7.86%.

The market size of Reporter Gene Assays is substantial, driven by high demand in various research fields, including drug development, cancer research, and genetics. These assays are instrumental in high-throughput screening processes and play a critical role in pharmaceutical and biotech industries, academic research institutions, and clinical laboratories. The broad applicability and versatility of Reporter Gene Assays continue to propel their market growth, and experts predict that this trend will continue in the coming years due to ongoing advancements in gene-editing technologies and the rising importance of precision medicine.

Reporter Gene Assay Market Share and Analysis

In recent years, the Reporter Gene Assay market share has seen considerable growth, primarily due to the increasing adoption of advanced gene expression technologies in research and diagnostics. The market is segmented by type (luminescent, fluorescent, and colorimetric assays), application (drug discovery, disease research, gene therapy, and others), and end-user (pharmaceutical companies, academic research institutions, and diagnostic labs). Among these, the luminescent Reporter Gene Assay segment holds a significant market share due to its high sensitivity and suitability for high-throughput screening.

Key players in the Reporter Gene Assay market, including Promega Corporation, Thermo Fisher Scientific, and Merck KGaA, are investing heavily in R&D to introduce innovative products and expand their product portfolios. North America leads the market in terms of revenue, followed closely by Europe, while the Asia-Pacific region is expected to witness the fastest growth due to increased investment in biotech research and development. In-depth Reporter Gene Assay analysis indicates that the market’s competitive landscape is shaped by collaborations, partnerships, and acquisitions aimed at expanding the technological capabilities of major companies and providing comprehensive solutions to end-users.

Reporter Gene Assay Trends

Several trends are shaping the Reporter Gene Assay market. First, there is an increased focus on the development of non-toxic, highly sensitive reporter genes to facilitate real-time and in vivo imaging, which is crucial for studying gene expression in living organisms. Second, the rising demand for Reporter Gene Assays in personalized medicine and targeted therapies is driving market growth. These assays allow researchers to determine the therapeutic efficacy of drugs on a molecular level, which is essential in creating personalized treatment plans. Third, technological advancements, such as automation and miniaturization, are making these assays more accessible and efficient, further boosting their popularity in laboratories worldwide. Additionally, the emergence of CRISPR-based reporter gene editing is revolutionizing Reporter Gene Assay applications, providing higher precision and efficiency in genetic research.

Reasons to Buy Reporter Gene Assay Reports

Comprehensive Market Insights: Reporter Gene Assay reports offer in-depth insights into market trends, competitive landscapes, and emerging applications, making them invaluable resources for researchers and industry professionals.

Data-Driven Analysis: These reports provide accurate data on market size, share, growth forecasts, and detailed analysis of market segments and regional performance.

Technological Developments: Reporter Gene Assay reports highlight recent technological advancements and innovations, allowing users to stay ahead in this rapidly evolving field.

Investment Opportunities: The reports identify investment opportunities and strategic recommendations for businesses aiming to expand their footprint in the Reporter Gene Assay market.

Regulatory Insights: With the growing importance of regulatory standards in gene research, the reports provide essential regulatory information relevant to the Reporter Gene Assay market, ensuring compliance for stakeholders.

Recent Developments

Recent developments in the Reporter Gene Assay market reflect ongoing innovation and growth. For instance, there have been significant advancements in bioluminescent and fluorescent reporter genes that enhance assay sensitivity and reduce background noise, making it easier for researchers to obtain accurate results. Major companies are also introducing next-generation Reporter Gene Assay kits designed for high-throughput screening and automated systems, improving assay efficiency and throughput. Additionally, collaborations between industry players and academic institutions have led to the development of new assay formats tailored for emerging fields like synthetic biology and precision oncology.

Overall, the Reporter Gene Assay market is expected to continue expanding as researchers increasingly rely on these assays for detailed gene expression analysis. These recent developments and trends make Reporter Gene Assay technology an indispensable tool for advancing molecular biology research and personalized medicine applications.

Related reports:

weight loss drugs market

portable ultrasound market

3d printed drugs market

[harshnews]

Plant Genomics Market Size, Share, Trends, Growth Opportunities and Competitive Outlook

"Global Plant Genomics Market - Industry Trends and Forecast to 2029

Global Plant Genomics Market, By Type (Molecular Engineering, Genetic Engineering and Genome Editing and Others), Trait (Yield Improvement, Disease Resistance, Herbicide Tolerance and Others), Objective (DNA Extraction & Purification, DNA/RNA Sequencing, Genotyping, Gene Expression Profiling, Marker-Assisted Selection, GMO-trait Purity Testing, Hybrid Purity Testing, Targeted Resequencing, DNA Parentage Testing, QTL Mapping,  and Genetic Disease), Application (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, Sugar Crops, Ornamentals and Alfalfa), Country (U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029

Access Full 350 Pages PDF Report @

**Segments**

- On the basis of application, the plant genomics market is segmented into transcriptomics, proteomics, metabolomics, and others. Transcriptomics involves the study of RNA molecules to understand gene expression levels, while proteomics focuses on studying proteins to unravel their functions. Metabolomics analyzes the metabolites within a cell or organism to gain insights into metabolic pathways and biochemical processes.

- In terms of technique, the market can be categorized into molecular markers, DNA sequencing, gene expression analysis, and other techniques. Molecular markers such as SSRs (Simple Sequence Repeats) and SNPs (Single Nucleotide Polymorphisms) are crucial for genetic mapping and marker-assisted breeding. DNA sequencing plays a fundamental role in deciphering plant genomes, while gene expression analysis helps in understanding how genes are regulated and activated.

- Based on end-users, the plant genomics market is segmented into academic research institutes, biotechnology companies, pharmaceutical companies, and others. Academic research institutes are at the forefront of exploring new frontiers in plant genomics, while biotechnology and pharmaceutical companies leverage genomics data for developing genetically modified crops, novel therapeutics, and plant-based products.

**Market Players**

- Some prominent players in the plant genomics market include Illumina Inc., Thermo Fisher Scientific Inc., Eurofins Scientific, Qiagen, Agilent Technologies, Biomatters Ltd., KeyGene, Danaher, LC Sciences, and PerkinElmer. These companies are heavily invested in developing cutting-edge genomics technologies, such as next-generation sequencing platforms, bioinformatics tools, and molecular markers for precision breeding programs. Illumina, in particular, is known for its high-throughput sequencing systems that have revolutionized genomics research across various sectors.

- Additionally, academic research institutions like the Boyce Thompson Institute, Max Planck Institute for Plant Breeding Research, and John Innes Centre play a significant role in advancing plant genomics through collaborative research, knowledge sharing, and technology transfer. ThesePlant genomics market is experiencing significant growth due to the increasing demand for sustainable agriculture practices, rising food security concerns, and advancements in genomic technologies. The application segment of the market plays a crucial role in understanding the complexities of plant biology. Transcriptomics, proteomics, and metabolomics provide valuable insights into gene expression, protein functions, and metabolic pathways, respectively, enabling researchers to develop crop varieties with desirable traits such as higher yield, stress resistance, and nutritional content. As the understanding of plant genomes deepens, the potential for targeted genetic modifications and precision breeding increases, driving the growth of the plant genomics market.

Technological advancements have propelled the plant genomics market forward, with molecular markers, DNA sequencing, and gene expression analysis being key techniques for studying plant genomes. Molecular markers like SSRs and SNPs are essential for genetic mapping and marker-assisted breeding programs, leading to the development of improved crop varieties with increased productivity and resilience to biotic and abiotic stresses. DNA sequencing has revolutionized the field of genomics by enabling the rapid and cost-effective decoding of plant genomes, facilitating genome-wide association studies and comparative genomics analyses. Gene expression analysis complements sequencing data by providing insights into how genes are regulated and function under different environmental conditions, offering valuable information for crop improvement strategies and trait selection.

The plant genomics market is driven by a diverse set of end-users, including academic research institutes, biotechnology companies, and pharmaceutical companies. Academic institutions play a crucial role in fundamental research and discovery, pushing the boundaries of plant genomics through collaboration and knowledge sharing. Biotechnology and pharmaceutical companies leverage genomics data to develop genetically modified crops, biopharmaceuticals, and plant-based products with enhanced traits and functionalities. These industry players drive innovation in plant genomics by translating research findings into practical applications that address global challenges such as food insecurity, climate change, and sustainable agriculture practices.

Prominent market players such as Illumina Inc., Thermo Fisher Scientific Inc., and Qiagen are at the**Segments:** - Molecular Engineering - Genetic Engineering and Genome Editing - Others

**Trait:** - Yield Improvement - Disease Resistance - Herbicide Tolerance - Others

**Objective:** - DNA Extraction & Purification - DNA/RNA Sequencing - Genotyping - Gene Expression Profiling - Marker-Assisted Selection - GMO-trait Purity Testing - Hybrid Purity Testing - Targeted Resequencing - DNA Parentage Testing - QTL Mapping - Genetic Disease

**Application:** - Cereals & Grains - Oilseeds & Pulses - Fruits & Vegetables - Sugar Crops - Ornamentals - Alfalfa

Global Plant Genomics Market is witnessing remarkable growth driven by advancements in genomic technologies and the increasing demand for sustainable agriculture solutions. The market segments based on molecular engineering, genetic engineering, and genome editing are pivotal in shaping the future of plant genomics research and application. Traits like yield improvement, disease resistance, and herbicide tolerance are key focus areas for developing genetically modified crops with enhanced characteristics. Objectives such as DNA extraction, genotyping, and gene expression profiling are instrumental in unraveling the genetic makeup of plants for targeted breeding and trait selection, contributing to agricultural innovation and productivity.

The application of plant genomics spans across various crops such as cereals, oilseeds, fruits, and vegetables, addressing specific needs in different agricultural sectors. The global market analysis

Major Points Covered in TOC:

Plant Genomics Market Overview: It incorporates six sections, research scope, significant makers covered, market fragments by type, Plant Genomics Market portions by application, study goals, and years considered.

Plant Genomics Market Landscape: Here, the opposition in the Worldwide Plant Genomics Market is dissected, by value, income, deals, and piece of the pie by organization, market rate, cutthroat circumstances Landscape, and most recent patterns, consolidation, development, obtaining, and portions of the overall industry of top organizations.

Plant Genomics Profiles of Manufacturers: Here, driving players of the worldwide Plant Genomics Market are considered dependent on deals region, key items, net edge, income, cost, and creation.

Plant Genomics Market Status and Outlook by Region: In this segment, the report examines about net edge, deals, income, creation, portion of the overall industry, CAGR, and market size by locale. Here, the worldwide Plant Genomics Market is profoundly examined based on areas and nations like North America, Europe, China, India, Japan, and the MEA.

Plant Genomics Application or End User: This segment of the exploration study shows how extraordinary end-client/application sections add to the worldwide Plant Genomics Market.

Plant Genomics Market Forecast: Production Side: In this piece of the report, the creators have zeroed in on creation and creation esteem conjecture, key makers gauge, and creation and creation esteem estimate by type.

Keyword: Research Findings and Conclusion: This is one of the last segments of the report where the discoveries of the investigators and the finish of the exploration study are given.

Browse Trending Reports:

Forage Harvester Market Calcify Uremic Arteriolopathy Drug Market Alexipharmic Drugs Market Resectoscope Market Coal To Liquid Market Air Electrode Battery Market Power Sports Batteries Market Body Scrub Market Cataplexy Treatment Market Alveolar Capillary Dysplasia Treatment Market Quantum Computing Market Control Valves Market Hemodialysis Peritoneal Dialysis Market Breathable Films Market Utility Locator Market Food Humectants Market Electronic Safety System Market Reporter Gene Assay Market Security Assertion Markup Language Saml Authentication Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[mmarketdbmr]

Surgical Chips Market – Industry Trends and Forecast to 2028 Scope: Growth, Share, Value, Size, and Analysis

Surgical Chips Market Size And Forecast by 2032

According to Data Bridge Market Research The global surgical chips market size was valued at USD 3.29 billion in 2024 and is projected to reach USD 6.22 billion by 2032, with a CAGR of 8.29% during the forecast period of 2025 to 2032. 

Our comprehensive Surgical Chips Market report is ready with the latest trends, growth opportunities, and strategic analysis. https://www.databridgemarketresearch.com/reports/global-surgical-chips-market

**Segments**

- **Product Type**: The surgical chips market can be segmented based on product type into biochips, gene chips, and drug discovery chips. Biochips are widely used for disease diagnosis and monitoring, gene chips help in studying gene expressions, and drug discovery chips are essential for drug development and testing.

- **Application**: Segmentation by application includes cancer diagnostics, genetic analysis, drug discovery, and others. Cancer diagnostics segment holds a significant share due to the increasing prevalence of cancer worldwide. Genetic analysis is also a key application area for surgical chips due to the rising demand for personalized medicine.

- **End-User**: The market can be segmented by end-user into hospitals, diagnostic centers, research institutes, and others. Hospitals are the primary end-users of surgical chips as they perform various surgical procedures that require advanced diagnostic tools for precise results.

**Market Players**

- **Thermo Fisher Scientific Inc.**: A leading player in the surgical chips market with a wide range of products and a strong global presence.

- **Illumina, Inc.**: Known for its innovative gene sequencing technologies, Illumina is a key player in the market offering cutting-edge solutions in the field of surgical chips.

- **QIAGEN**: Specializing in sample and assay technologies for molecular diagnostics, QIAGEN is a prominent player in the surgical chips market.

- **PerkinElmer Inc.**: With a focus on improving human and environmental health through its technologies, PerkinElmer is a major player in the market offering advanced surgical chip solutions.

- **Agilent Technologies**: Known for its expertise in chemical analysis and diagnostics, Agilent Technologies is a significant player in the surgical chips market providing high-quality products and services.

The global surgical chips market is witnessing significant growth and innovation with key players focusing on research and development to introduce advanced and efficient surgical chip solutions. With the increasing prevalence of chronic diseases and the growing demand for personalized medicine, the market is poised for further expansion. Technological advancements in the field of surgical chips, along with strategic partnerships and collaborations among market players, are expected to drive market growth in the coming years.

https://www.databridgemarketresearch.com/reports/global-surgical-chips-market The global surgical chips market is characterized by intense competition and rapid technological advancements, driving innovation and market growth. In addition to the key players mentioned, the market landscape includes various emerging players and startups vying for market share by introducing disruptive technologies and solutions. These new entrants are enhancing competition in the market, compelling established players to further innovate and differentiate their offerings to maintain their competitive edge.

One of the emerging trends in the surgical chips market is the increasing focus on personalized medicine and precision healthcare. As advancements in genomics and molecular diagnostics continue to evolve, the demand for surgical chips that enable precise and targeted treatment strategies is on the rise. This trend is fueled by the growing awareness among healthcare professionals and patients regarding the potential benefits of personalized medicine in improving treatment outcomes and reducing healthcare costs.

Another key trend shaping the market is the rising adoption of artificial intelligence (AI) and machine learning in surgical chip technology. These advanced technologies are being integrated into surgical chips to enhance diagnostic accuracy, streamline workflow processes, and enable real-time data analysis. AI-driven surgical chips have the potential to revolutionize surgical procedures by providing healthcare professionals with valuable insights and predictive analytics to support clinical decision-making.

Furthermore, collaborations and partnerships between market players, research institutions, and healthcare providers are playing a crucial role in driving innovation in the surgical chips market. By pooling resources, expertise, and technology, stakeholders in the industry can accelerate the development of next-generation surgical chip solutions that address unmet clinical needs and improve patient outcomes. These collaborative efforts are also fostering knowledge sharing and cross-pollination of ideas, leading to the rapid advancement of surgical chip technology.

In terms of market dynamics, the increasing prevalence of chronic diseases and the aging population worldwide are significant drivers for the growth of the surgical chips market. Chronic conditions such as cancer, cardiovascular diseases, and neurological disorders require accurate and timely diagnoses for effective treatment planning and management. Surgical chips play a vital role in enabling early disease detection, monitoring disease progression, and guiding personalized treatment approaches, making them indispensable tools in modern healthcare practices.

Overall, the global surgical chips market is poised for substantial growth in the coming years, driven by technological advancements, increasing adoption of personalized medicine practices, and collaborative initiatives among industry stakeholders. As the market continues to evolve, strategic investments in research and development, regulatory compliance, and market expansion will be critical for companies to capitalize on emerging opportunities and position themselves for long-term success in this dynamic and competitive market landscape.**Segments**

Global Surgical Chips Market, By Type (DNA Chips, Brain Chips, Lab Chips, Protein Chips, Tissue Chip), Application (Cancer Diagnosis and Treatment, Gene Expression, SNP Genotyping, Genomics, Clinical Diagnostics), End Users (Hospitals, Research Centers, Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2032

**Market Players**

- The major players covered in the surgical chips market report are BD, Drägerwerk AG & Co. KGaA, Teleflex Incorporated, GENERAL ELECTRIC COMPANY, Getinge AB, Hamilton Medical, Medtronic, Koninklijke Philips N.V., Agilent Technologies, Inc., Abbott, F. Hoffmann-La Roche Ltd. ResMed, bioMérieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Thermo Fisher Scientific, SCIENION, Smith’s Group Plc, Eurofins Scientific and Macrogen, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The global surgical chips market is segmented based on product type, application, and end-user, showcasing a diverse landscape with various opportunities for growth and innovation. Product types such as DNA chips, brain chips, lab chips, protein chips, and tissue chips cater to specific needs in cancer diagnosis and treatment, gene expression studies, SNP genotyping, genomics, and clinical diagnostics. Different end-users including hospitals, research centers, clinics, and others further drive market demand across regions like the U.S., Canada, Mexico, European countries, Asian-Pacific regions, South America, and the Middle East & Africa.

Market players like BD, Teleflex Incorporated, Agilent Technologies, and Thermo Fisher Scientific are at the forefront of innovation and competition within the surgical chips market, offering a wide range of products and solutions to meet the evolving needs of healthcare providers and researchers. These key players are leveraging technologies like AI, machine learning, and molecular diagnostics to enhance the performance and efficiency of surgical chip solutions, thereby shaping the future of precision medicine and personalized healthcare.

The market dynamics are influenced by factors such as the increasing prevalence of chronic diseases, aging populations, and the rising adoption of personalized medicine practices globally. The demand for accurate and timely diagnostic tools like surgical chips is escalating, driving the market growth and spurring further investments in research and development. Collaborations and partnerships between industry stakeholders and healthcare providers are playing a vital role in accelerating innovation and expanding the market reach of surgical chip technologies.

In conclusion, the global surgical chips market presents a dynamic and competitive landscape with immense growth potential driven by advancements in technology, increasing awareness of personalized medicine, and strategic collaborations among market players. With a forecasted outlook to 2032, the market is set to witness significant developments, leveraging cutting-edge solutions to address the complex healthcare challenges and improve patient outcomes on a global scale.

The market is highly fragmented, with a mix of global and regional players competing for market share. To Learn More About the Global Trends Impacting the Future of Top 10 Companies in Surgical Chips Market :   https://www.databridgemarketresearch.com/reports/global-surgical-chips-market/companies

Key Questions Answered by the Global Surgical Chips Market Report:

What is the current state of the Surgical Chips Market, and how has it evolved?

What are the key drivers behind the growth of the Surgical Chips Market?

What challenges and barriers do businesses in the Surgical Chips Market face?

How are technological innovations impacting the Surgical Chips Market?

What emerging trends and opportunities should businesses be aware of in the Surgical Chips Market?

Browse More Reports:

https://www.databridgemarketresearch.com/reports/global-marine-steering-system-markethttps://www.databridgemarketresearch.com/reports/global-automotive-window-rain-guard-markethttps://www.databridgemarketresearch.com/reports/global-sodium-dichloroisocyanurate-markethttps://www.databridgemarketresearch.com/reports/global-gastrointestinal-otc-drugs-markethttps://www.databridgemarketresearch.com/reports/global-contract-furniture-and-furnishing-market

Data Bridge Market Research:

☎ Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 982

✉ Email: corporatesales@databridgemarketresearch.com"

[healthcaremarketanalysis]

RNA Analysis Industry worth $9.9 billion by 2028, with a CAGR of 13.4%

The global RNA analysis market growth forecasted to transform from USD 5.3 billion in 2023 to USD 9.9 billion by 2028, driven by a CAGR of 13.4%. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market. Many peptide-based research projects are also being fostered by increasing collaborative partnerships among various companies that are driving market growth.

Download an Illustrative overview:

Browse in-depth TOC on "RNA Analysis Market"

178 - Tables

46 - Figures

263 - Pages

The reagents/consumables segment accounted for the largest share of the product & service segment in the RNA analysis market in 2022.

Based on product & service, the RNA analysis market is segmented into reagents/consumables, instruments, software, and services. In 2022, the reagents/consumables segment accounted for the largest share of the RNA analysis market. The large share of this segment is fueled by the increasing demand for omics-based therapeutics, expanding research and development activities, and the availability of various RNA analysis reagents in the market.

The PCR segment accounted for the largest share of the technology segment in the RNA analysis market in 2022.

Based on technology, the RNA analysis market is segmented into PCR, sequencing, microarrays, and RNA interference. The PCR segment accounted for the largest share in the RNA analysis market in 2022. PCR is associated with several advantages, such as ease of operation, and short production cycles. These advantages support the growth of the PCR in the RNA analysis segment.

Asia Pacific is likely to grow at the highest growth rate during the forecast period.

Based on the region The global RNA analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional segment. The Asia Pacific region is estimated to grow at the highest CAGR in the RNA analysis market during the forecast period. The growth of the pharmaceuticals market in the region is primarily driven by the increasing prevalence of chronic diseases, the rising disposable incomes, the growing focus on personalized medicine, and the increasing government support for genomics and proteomics.

Request Sample Pages:

RNA Analysis Market Dynamics:

Drivers:

Growing demand for personalized medicine

Restraints:

High capital investments

Opportunities:

Opportunities in Emerging Countries

Challenges:

Data management in transcriptomics research

Key Market Players:

The prominent players operating in the RNA analysis market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), and Eurofins Scientific (Luxembourg).

Recent Developments:

In October 2022, Agilent Technologies and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.

In March 2022, Eurofins acquired Beacon Discovery, a drug discovery-based CRO. Beacon supported the fully integrated drug discovery programs from target validation to pre-clinical candidates.

In January 2021, Thermo Fisher acquired Phitonex to provide greater flow cytometry and imaging multiplexing capabilities for protein and cell analysis research needs. Phitonex's product offerings are also an expansion of the company's existing protein and cell analysis portfolio.

Get 10% Free Customization on this Report:

RNA Analysis Market Advantages:

Unraveling Gene Expression: RNA analysis allows researchers to study the dynamic gene expression patterns in cells and tissues, providing valuable insights into how genes are regulated and how they respond to different stimuli, disease conditions, or treatments.

Disease Understanding: By analyzing RNA profiles, scientists can gain a deeper understanding of the molecular basis of various diseases, including cancer, neurological disorders, and infectious diseases. This knowledge can lead to the identification of biomarkers and potential therapeutic targets.

Personalized Medicine: RNA analysis has the potential to enable personalized medicine approaches. By profiling an individual's RNA, clinicians can tailor treatments to the patient's specific genetic makeup and disease characteristics, increasing treatment efficacy and minimizing adverse effects.

Advancements in Therapeutics: RNA analysis plays a crucial role in the development of novel RNA-based therapeutics, such as RNA interference (RNAi) and mRNA vaccines. These groundbreaking treatments have the potential to target specific genes and revolutionize disease management.

Diagnostic Applications: RNA analysis offers a wide range of diagnostic applications. From detecting infectious agents to identifying specific genetic mutations associated with diseases, RNA-based diagnostic tests can provide faster, more accurate results than traditional methods.

Biotechnology and Drug Development: In the biotechnology and pharmaceutical industries, RNA analysis is utilized to assess the safety and efficacy of potential drugs. It helps identify potential drug targets and provides valuable information during preclinical and clinical trials.

Agricultural Advancements: RNA analysis is also applied in agriculture to improve crop yields, develop disease-resistant varieties, and enhance the nutritional content of food.

Non-Invasive Testing: In certain cases, RNA analysis can be performed on non-invasive samples such as blood, urine, or saliva, reducing the need for invasive procedures and making it easier to monitor patients over time.

Technological Advancements: The RNA analysis market is continuously evolving with advancements in sequencing technologies, bioinformatics, and automation. These innovations have led to increased throughput, reduced costs, and improved accuracy in data analysis.

Research Tools: The availability of diverse RNA analysis tools and kits allows researchers to perform experiments efficiently and cost-effectively, fostering a broader adoption of RNA-focused studies across academic and commercial laboratories.

Overall, the growing advantages of RNA analysis have positioned it as a pivotal component in advancing our understanding of biology, driving medical breakthroughs, and shaping the future of personalized medicine and precision healthcare.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1-888-600-6441

UK +44-800-368-9399

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

[anujmrfr]

Gene Chip Market Size, Growth Outlook 2035

The global Gene Chip Market Size was estimated at 1.97 (USD Billion) in 2024. The Gene Chip Market Industry is expected to grow from 2.11 (USD Billion) in 2025 to 3.94 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.17% during the forecast period (2025 - 2034).

Market Overview The Gene Chip Market is witnessing significant growth due to the rising adoption of genomics in disease research, personalized medicine, and drug discovery. Gene chips, also known as DNA microarrays, are widely used for gene expression profiling, mutation detection, and genotyping applications. The increasing prevalence of genetic disorders, cancer, and infectious diseases, coupled with advancements in bioinformatics and next-generation sequencing (NGS) technologies, is driving market expansion. Furthermore, growing investments in genomic research and precision medicine are accelerating the demand for gene chip technologies.

Market Size and Share The global Gene Chip MarketSize was estimated at 1.97 (USD Billion) in 2024. The Gene Chip Market Industry is expected to grow from 2.11 (USD Billion) in 2025 to 3.94 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.17% during the forecast period (2025 - 2034). North America dominates the market due to the presence of major biotechnology firms, well-established research institutions, and high investments in precision medicine. The Asia-Pacific gene chip market is expected to witness the fastest growth, driven by government initiatives in genomics, expanding healthcare infrastructure, and increasing demand for personalized medicine.

Market Drivers

Increasing Prevalence of Genetic and Chronic Diseases: Rising cases of cancer, hereditary disorders, and infectious diseases are boosting demand for DNA microarrays in diagnostic applications.

Advancements in Genomics and Bioinformatics: Integration of artificial intelligence (AI) in gene expression analysis is enhancing the accuracy of gene chip technology.

Growing Adoption of Personalized Medicine: The demand for customized treatment plans based on genetic profiling is fueling market growth.

Rising Investments in Drug Discovery and Development: Pharmaceutical companies are increasingly using gene chip assays for target identification and biomarker discovery.

Challenges and Restraints

High Cost of Gene Chip Technology: DNA microarray platforms can be expensive, limiting accessibility in low-income regions.

Data Complexity and Interpretation Challenges: The vast amount of genetic data generated by microarrays requires advanced bioinformatics tools and expertise.

Competition from Next-Generation Sequencing (NGS): The emergence of NGS technologies is challenging the market share of traditional gene chip platforms.

Market Trends

Miniaturization and Portability of Gene Chips: Development of lab-on-a-chip technologies is enhancing accessibility for point-of-care testing.

Integration of AI in Genomic Data Analysis: AI-powered gene expression analysis is improving accuracy in disease diagnosis and drug response prediction.

Increased Adoption of High-Density Microarrays: Researchers are leveraging high-throughput gene chips for cancer genomics and pharmacogenomics.

Regional Analysis

North America: The largest market due to high R&D investments, government funding for genomics, and strong presence of biotechnology firms.

Europe: Significant market growth driven by precision medicine initiatives and increasing applications in rare disease diagnostics.

Asia-Pacific: Fastest-growing region due to rising demand for personalized medicine, expanding research in genetics, and increasing adoption of gene chip technology.

Rest of the World: Moderate growth, particularly in Latin America and the Middle East, where genomics research is gradually expanding.

Segmental Analysis

By Type:

cDNA Microarrays

Oligonucleotide Microarrays

SNP Microarrays

By Application:

Gene Expression Analysis

Cancer Diagnostics

Pharmacogenomics

Pathogen Detection

Agricultural Genomics

By End-User:

Biotechnology & Pharmaceutical Companies

Academic & Research Institutes

Diagnostic Laboratories

Key Market Players

GE Healthcare

HoffmannLa Roche Ltd

Illumina, Inc.

Danaher Corporation

Siemens Healthineers

Thermo Fisher Scientific

BD (Becton, Dickinson and Company)

Recent Developments

Launch of AI-Based Gene Expression Profiling Platforms: Enhancing the efficiency of genomic data interpretation.

Advancements in Multiplex Microarray Technologies: Improving the sensitivity and specificity of gene chip assays.

Strategic Partnerships Between Pharma and Genomics Firms: Accelerating the development of biomarker-driven drug discovery.

For more information, please visit us at marketresearchfuture.

[industrynewsupdates]

Astaxanthin Market Segmentation and Competitive Analysis Report 2024 - 2030

The global astaxanthin market size was valued at USD 2.34 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. 

Growing demand for astaxanthin is being fueled by its increasing use in various industries, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages, among others. It is widely used as a food ingredient for prawns and fishes such as salmon, trout, & ornamental fishes to enhance their coloration and increase commercial value. Other benefits for aquatic animals include growth in stress tolerance, performance, immune-related gene expressions, reproductive capacity, improvement in survival, and disease resistance. Major players are focusing on new product developments and collaborative agreements to meet the increasing demand for astaxanthin in aquaculture.

Additionally, presence of organizations that actively promote awareness regarding diverse applications of these products is expected to further drive market growth. For instance, the Natural Algae Astaxanthin Association (NAXA) plays a key role in promoting, protecting, and educating about the benefits of natural astaxanthin in various end-use applications.The association supports research related to natural astaxanthin and certifies products with NAXA Verification Seal.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market

Astaxanthin Market Report Highlights

• Based on product, the dried algae meal or biomass segment accounted for the largest share in 2023 due to the high usage as animal feed and lower cost of production

• The aquaculture & animal feed segment was the highest revenue contributor in 2023. Whereas, the nutraceuticals segment is expected to exhibit the fastest CAGR during the projected period

• The Asia Pacific region is expected to grow at the fastest rate over the forecast period due to the rising investments by market players and increasing research activities in the region

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

• The global antiarrhythmic drugs market size was valued at USD 1.05 billion in 2023 and is projected to grow at a CAGR of 6.4% from 2024 to 2030. 

• The global amyloidosis treatment market size was valued at USD 5.39 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2030.

Astaxanthin Market Segmentation

Grand View Research has segmented the global astaxanthin market on the basis of source, product, application, and region

Astaxanthin Source Outlook (Revenue, USD Million, 2018 - 2030) (Volumein Metric Tonnes)

• Natural

o Yeast

o Krill/Shrimp

o Microalgae

o Others

• Synthetic

Astaxanthin Product Outlook (Revenue, USD Million, 2018 - 2030)

• Dried Algae Meal or Biomass

• Oil

• Softgel

• Liquid

• Others

Astaxanthin Application Outlook (Revenue, USD Million, 2018 - 2030)

• Nutraceuticals

• Cosmetics

• Aquaculture And Animal Feed

• Food

o Functional Foods And Beverages

o Other Traditional Food Manufacturing Applications

• Others

Astaxanthin Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o U.K.

o Germany

o France

o Italy

o Spain

o Russia

o Denmark

o Norway

o Sweden

• Asia Pacific

o Japan

o China

o India

o South Korea

o Australia

o Singapore

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

o Ecuador

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Israel

o Kuwait

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.

[tamanna31]

New Trends of Oligonucleotide Synthesis Market with Industry Analysis by 2024 – 2030

Oligonucleotide Synthesis Industry Overview

The global oligonucleotide synthesis market size was estimated at USD 3.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. 

The decreasing prices of sequencing have led to increasing demand for custom-made nucleotides for applications across genetic testing, research, forensics applications, and drug development. This has further boosted the demand for oligonucleotide synthesis. The COVID-19 pandemic has affected every market globally and there has been a surge in the demand for efficient treatment against COVID-19.

Gather more insights about the market drivers, restrains and growth of the Oligonucleotide Synthesis Market

Oligonucleotide therapeutics hold immense potential for treating chronic conditions such as cardiovascular diseases, cancers, and retinal disorders. Emerging new applications of oligo sequences in multiple fields of biotechnology are expected to increase market growth. Demand for molecular diagnostics in precision care is an important emerging application field for oligonucleotide synthesis.

The introduction of advanced techniques such as CRISPR and high-throughput sequencing for gene expression analysis has simplified the genetic screening and modification of genomes. Such innovations are observed to influence the demand for oligonucleotide synthesis. Manufacturers invest in technology development to enable the production of long Oligonucleotides with higher precision and better yield to cater to the growing need for custom oligos.

The availability of a regulatory environment that supports the progress of genomics is the key factor contributing to the market growth. Changes in the regulatory policies to provide a well-framed environment for advanced biological research and application in human use are expected to influence demand for oligonucleotide synthesis significantly. Stem cells, regenerative medicine, genetic engineering, and synthetic biology are the prominent fields identified with high potential in healthcare. For instance, the International Society for Stem Cell Research (ISSCR) ethics and public policy committee aims to recognize and resolve issues by conducting open discussions. The committee includes experts in ethics, law, and social policy worldwide.

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Some of the key players operating in the market include Merck KGaA, Thermo Fisher Scientific, Inc., and Agilent Technologies. These players focus on business strategies such as partnerships/collaborations, product launches, and expansion. Twist Bioscience, Biolegio, and LGC Biosearch Technologies are some of the emerging market participants in the oligonucleotide market. These players primarily focus on expansion and partnerships to strengthen their position in the market.

Key Oligonucleotide Synthesis Companies:

·         Thermo Fisher Scientific, Inc.

·         Merck KGaA

·         Danaher Corporation

·         Dharmacon Inc.

·         Agilent Technologies

·         Bio-synthesis

·         Kaneka Eurogentec S.A

·         LGC Biosearch Technologies

·         Biolegio

·         Twist Bioscience

Recent Developments

In October 2023, IDT inaugurated a new therapeutic manufacturing facility to meet the increasing demand in genomic medicine. The new facility is equipped to support the production of therapeutic oligonucleotides, catering to the expanding needs in the field of genomics and personalized medicine.

In September 2023, Danaher Corporation (Integrated DNA Technologies) introduced a range of xGen NGS products tailored for the Ultima Genomics UG 100TM platform. The suite includes adapters, primers, and universal blockers, catering to various applications such as DNA, RNA, & methylation sequencing workflows. This offering is complemented by IDT's proven hybridization capture chemistry, enhancing versatility for researchers.

In July 2023, Analytix introduced two new instruments designed for organic synthesis, including wavePREP, tailored for oligonucleotide synthesis, and Xelsius, a workstation for multireaction synthesis.

In May 2023, GenScript expanded its life sciences facility in Zhenjiang, Jiangsu, China, to offer a rapid, high-purity oligonucleotide and peptide synthesis service tailored for research & development as well as preclinical applications.

In May 2023, Twist Bioscience and CeGaT GmbH launched the Twist Alliance CeGaT RNA Fusion Panel. This collaborative effort aims to provide a specialized tool for oncology research, facilitating the detection of RNA fusions and enabling transcript variant analysis. RNA fusions, a result of chromosomal arrangements often seen in cancers, can now be efficiently studied using this newly introduced panel.

In February 2023, Fluor Corp. and Agilent Technologies, Inc. collaborated to enhance its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado. Under this collaboration, Fluor is expected to support the project's engineering and procurement. The total value of the project is evaluated at USD 725 million.

Order a free sample PDF of the Oligonucleotide Synthesis Market Intelligence Study, published by Grand View Research.